TY - JOUR
T1 - Metabonomic profiling of diet-induced hyperlipidaemia in a rat model
AU - Zhang, Qi
AU - Wang, Guangji
AU - A, Jiye
AU - Ma, Bo
AU - Dua, Yu
AU - Zhu, Lingling
AU - Wu, Di
PY - 2010/5
Y1 - 2010/5
N2 - This study describes the metabolic profiles of the development of hyperlipidaemia in a rat model, utilizing metabonomics by gas chromatographymass spectrometry (GC-MS) determination coupled with multivariate statistical analysis. Rat plasma samples were collected before and during a high-lipid diet at days 0, 7, 14, 21 and 28, and were analysed for lipid levels using kit assays or metabonomics using GC-MS. Forty-one endogenous metabolites were separated, identified and quantified using GC-MS. The data matrix was processed by principal component analysis or partial least squares discriminant analysis. Dynamic modification of the rat metabonome can be clearly identified and tracked at different stages of hyperlipidaemia in the rat model. Potential biomarkers, including β-hydroxybutyrate, tyrosine and creatinine, were identified. The current work suggests that metabonomics is able to provide an overview of biochemical profiles of disease progress in animal models. Using a metabonomic approach to identify physiopathological states promises to establish a new methodology for the early diagnosis of human diseases.
AB - This study describes the metabolic profiles of the development of hyperlipidaemia in a rat model, utilizing metabonomics by gas chromatographymass spectrometry (GC-MS) determination coupled with multivariate statistical analysis. Rat plasma samples were collected before and during a high-lipid diet at days 0, 7, 14, 21 and 28, and were analysed for lipid levels using kit assays or metabonomics using GC-MS. Forty-one endogenous metabolites were separated, identified and quantified using GC-MS. The data matrix was processed by principal component analysis or partial least squares discriminant analysis. Dynamic modification of the rat metabonome can be clearly identified and tracked at different stages of hyperlipidaemia in the rat model. Potential biomarkers, including β-hydroxybutyrate, tyrosine and creatinine, were identified. The current work suggests that metabonomics is able to provide an overview of biochemical profiles of disease progress in animal models. Using a metabonomic approach to identify physiopathological states promises to establish a new methodology for the early diagnosis of human diseases.
KW - Early diagnosis
KW - GC-MS
KW - Hyperlipidaemia
KW - Metabonomics
KW - Partial least squares discriminant analysis
KW - Principal component analysis
UR - http://www.scopus.com/inward/record.url?scp=77951677264&partnerID=8YFLogxK
U2 - 10.3109/13547500903419049
DO - 10.3109/13547500903419049
M3 - 文章
C2 - 20001218
AN - SCOPUS:77951677264
SN - 1354-750X
VL - 15
SP - 205
EP - 216
JO - Biomarkers
JF - Biomarkers
IS - 3
ER -